Aromatherapy Inhaler Use for Hematopoietic Stem Cell Transplant Patient Distress
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The purpose of this research is to evaluate aromatherapy inhaler use and how it may impact cancer distress and coping by patients in the first few days after hematopoietic stem cell transplant (HSCT).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Healthy Volunteers: f
View:
• Autologous and Allogeneic patients admitted to E1 for planned HSCT
• Patients with hematologic malignancies requiring HSCT
• No allergies to lavender or peppermint essential oils
• Must have received chemotherapy during preparative regimen (single or multi-agent regimen)
• Adult patient over 18 years of age
• Able to speak, read, and comprehend English
• Willing and capable of providing informed consent
Locations
United States
California
Stanford University
RECRUITING
Stanford
Contact Information
Primary
Aubrey Florom-Smith, PhD, RN
aubsmith@stanford.edu
650-285-9512
Time Frame
Start Date: 2025-06-16
Estimated Completion Date: 2026-03
Participants
Target number of participants: 50
Treatments
Other: SOC only then SOC plus Aromatherapy Inhaler
1. Participant will receive standard of care pharmacological intervention (SOC) as needed throughout the day.~2. Participants will complete the Standard of Care Pharmacological Intervention Use Log.~3. At between 1300 and 1500 hours, study personnel will administer the NCCN Distress Thermometer and Problem List.
Other: SOC and Aromatherapy Inhaler then SOC only
1. Participant will use the aromatherapy inhaler as needed for up to two (2) hours in the morning and complete the Aromatherapy Inhaler Use Log.~2. At between 1300 and 1500 hours, study personnel will administer the NCCN Distress Thermometer and Problem List.
Authors
Related Therapeutic Areas
Sponsors
Leads: Stanford University